Detailed Information

Cited 2 time in webofscience Cited 2 time in scopus
Metadata Downloads

Self-Monitoring of Blood Pressure and Feed-back Using APP in TReatment of UnconTrolled Hypertension (SMART-BP): A Randomized Clinical Trial

Authors
Choi, Dong-JuPark, Jin JooYoon, MinjaePark, Sung-JiJo, Sang-HoKim, Eung JuKim, Soo-JoongLee, Sungyoung
Issue Date
Oct-2022
Publisher
대한심장학회
Keywords
Hypertension; Blood pressure; Mobile health; Medication adherence
Citation
Korean Circulation Journal, v.52, no.10, pp 785 - 794
Pages
10
Indexed
SCIE
SCOPUS
KCI
Journal Title
Korean Circulation Journal
Volume
52
Number
10
Start Page
785
End Page
794
URI
https://scholarworks.korea.ac.kr/kumedicine/handle/2021.sw.kumedicine/61968
DOI
10.4070/kcj.2022.0133
ISSN
1738-5520
1738-5555
Abstract
Background and Objectives Self-monitoring of blood pressure (SMBP) is a reliable method used to assess BP accurately. However, patients do not often know how to respond to the measured BP value. We developed a mobile application-based feed-back algorithm (SMBP-App) for tailored recommendations. In this study, we aim to evaluate whether SMBP-App is superior to SMBP alone in terms of BP reduction and drug adherence improvement in patients with hypertension. Methods Self-Monitoring of blood pressure and Feed-back using APP in TReatment of UnconTrolled Hypertension (SMART-BP) is a prospective, randomized, open-label, multicenter trial to evaluate the efficacy of SMBP-App compared with SMBP alone. Patients with uncomplicated essential hypertension will be randomly assigned to the SMBP-App (90 patients) and SMBP alone (90 patients) groups. In the SMBP group, the patients will perform home BP measurement and receive the standard care, whereas in the SMBP-App group, the patients will receive additional recommendations from the application in response to the obtained BP value. Follow-up visits will be scheduled at 12 and 24 weeks after randomization. The primary endpoint of the study is the mean home systolic BP. The secondary endpoints include the drug adherence, the home diastolic BP, home and office BP. Conclusions SMART-BP is a prospective, randomized, open-label, multicenter trial to evaluate the efficacy of SMBP-App. If we can confirm its efficacy, SMBP-App may be scaled-up to improve the treatment of hypertension.
Files in This Item
There are no files associated with this item.
Appears in
Collections
2. Clinical Science > Department of Cardiology > 1. Journal Articles

qrcode

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.

Related Researcher

Researcher Kim, Eung Ju photo

Kim, Eung Ju
Guro Hospital (Department of Cardiology, Guro Hospital)
Read more

Altmetrics

Total Views & Downloads

BROWSE